Status:

UNKNOWN

Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

DexCom, Inc.

Conditions:

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Dysglycemia

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

PCOS is the most common endocrine disorder of reproductive aged women. In addition to menstrual and endocrine abnormalities, PCOS is characterized by insulin resistance and glycemic dysregulation. The...

Detailed Description

Study synopsis: Recruitment: * PCOS participants will be recruited from those who are being seen or have previously been seen at the UCSF multidisciplinary PCOS clinic. * Non-PCOS participants will ...

Eligibility Criteria

Inclusion

  • For aim 1:
  • Aged 18-45
  • Female sex
  • Agree to wear a CGM for 10 days
  • Have access to an apple or android smart phone for CGM monitoring
  • Are able to be characterized as PCOS or non-PCOS using the 2003 Rotterdam criteria for PCOS of 2 or more of the following: 1) biochemical or clinical hyperandrogenism, 2) polycystic ovarian morphology on transvaginal ultrasound, and/or 3) oligo-amenorrhea
  • For aim 2:
  • All of the inclusion criteria for aim 1
  • Meet 2003 Rotterdam criteria for PCOS as above
  • Evidence of baseline glycemic dysregulation including any of the following: 1) elevated fasting glucose (100-125 mg/dL), 2) elevated 2 hour glucose (140-200 mg/dL), 3) elevated fasting insulin (\>10 mIU/mL), 4) elevated 2 hour insulin (\>40 mIU/mL), 5) elevated Hgba1c (5.7- 6.4)

Exclusion

  • For both aims 1 and 2:
  • Use of metformin or other anti-diabetic agents
  • Diagnosis of type I or II diabetes mellitus (including those found to have fasting glucose \>126, 2 hour glucose \>200, Hgba1c \>6.5)
  • Prior or current use of CGM

Key Trial Info

Start Date :

November 29 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2025

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT06050265

Start Date

November 29 2023

End Date

July 1 2025

Last Update

November 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCSF Center for Reproductive Health

San Francisco, California, United States, 94158

Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome | DecenTrialz